2025 annual financial data
ANI Pharmaceuticals 2025 Operating margin
Direct answer
Operating margin was 9.2%.
Operating income was 81,230,000 USD and net income was 78,337,000 USD.
Operating cash flow was 185,225,000 USD.
Get free ANI Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 883,366,000 USD
- Operating income
- 81,230,000 USD
- Net income
- 78,337,000 USD
- Operating cash flow
- 185,225,000 USD